Back to Search
Start Over
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
- Source :
- Neuro-Oncology; Oct2024, Vol. 26 Issue 10, p1895-1911, 17p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 15228517
- Volume :
- 26
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Neuro-Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 180088012
- Full Text :
- https://doi.org/10.1093/neuonc/noae120